Compass therapeutics to participate in the stifel 2023 virtual targeted oncology days

Boston, april 19, 2023 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in the stifel 2023 virtual targeted oncology days, which is taking place on april 25 – 26, 2023.
CMPX Ratings Summary
CMPX Quant Ranking